<DOC>
	<DOC>NCT00723411</DOC>
	<brief_summary>The purpose of this study is to determine whether Diamyd (rhGAD65 formulated in alum) is effective in preserving the body's own insulin producing capacity in patients recently diagnosed with type 1 diabetes.</brief_summary>
	<brief_title>A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Main Male and female patients between 10 and 20 years of age Insulin dependent type 1 diabetes mellitus diagnosed within the previous 3 months at time of screening Fasting Cpeptide level at time of screening above 0.1 nmol/L Elevated GAD65 antibodies (GADA) at time of screening Main Treatment with immunosuppressants or any antidiabetic medications other than insulin A history of certain diseases or conditions (e.g. anemia, HIV, hepatitis, epilepsy, head trauma, neurological diseases or cerebrovascular accident, alcohol or drug abuse etc) Treatment with any vaccine within 1 month prior to planned first Diamyd dose or planned treatment with vaccine up to 2 months after the last injection with Diamyd, excluding the influenza vaccine Participation in other clinical trials with a new chemical entity within the previous 3 months Pregnancy or planned pregnancy within 1 year after the last Diamyd dose Presence of associated serious disease or condition which in the opinion of the investigator makes the patient noneligible for the study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Juvenile Diabetes</keyword>
	<keyword>Diabetes type 1</keyword>
	<keyword>Autoimmune Diabetes</keyword>
	<keyword>Insulin dependent Diabetes</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Type 1 diabetes mellitus</keyword>
	<keyword>Diamyd</keyword>
	<keyword>rhGAD65</keyword>
	<keyword>GAD</keyword>
	<keyword>GAD-alum</keyword>
</DOC>